Terazosin
NDC 69452-332, Terazosin, capsule, from Bionpharma Inc..
- Product NDC
- 69452-332
- Status
- Listed
- Labeler
- Bionpharma Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075667
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69452-332 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69452-332-20 | 69452033220 | 100 CAPSULE in 1 BOTTLE (69452-332-20) |
| 69452-332-32 | 69452033232 | 1000 CAPSULE in 1 BOTTLE (69452-332-32) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/130c84dc-b598-660f-e063-6294a90a8e46NADAC price for package 69452033220
GET /v1/drugs/nadac/69452033220NADAC price for package 69452033232
GET /v1/drugs/nadac/69452033232
Use it
Look up 69452-332 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69452-332 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69452-332. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.